Primary leiomyosarcoma of the uterine cervix: an unusual case and critical appraisal.
Cervix
cervical cancer
cervical sarcoma
leiomyosarcoma
sarcoma
uterine sarcoma
uterus
Journal
Journal of surgical case reports
ISSN: 2042-8812
Titre abrégé: J Surg Case Rep
Pays: England
ID NLM: 101560169
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
28
06
2023
accepted:
15
07
2023
medline:
7
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
Leiomyosarcomas of the uterine cervix are rare, mostly occurring in perimenopausal women. Diagnosis is based on pathology and immunohistochemistry. Surgery with a total abdominal hysterectomy and bilateral salpingo-oophorectomy remains the standard. A female patient in her 60s presented with heavy postmenopausal bleeding. Vaginal ultrasound scan and magnetic resonance imaging showed a large strongly vascularized cervical mass with features suspicious of sarcomatous degeneration. Positron Emission Tomography-Computed Tomography (PET-CT) did not reveal any evidence of metastases nor lymphadenopathy, but presence of right hydronephrosis. An abdominal hysterectomy with bilateral salpingo-oophorectomy, and end-to-end anastomosis of the right ureter, was performed. Pathology showed an International Federation of Gynecology and Obstetrics (FIGO)-stage 1B leiomyosarcoma of the uterine cervix. No adjuvant treatment was given. Adjuvant radiotherapy reduces the risk of recurrence but no survival impact. The benefit of adjuvant chemotherapy is questionable given the lack of randomized trials. Multidisciplinary research concerning molecular alterations of the disease is required to determine optimal management strategies with potential novel molecular therapies.
Identifiants
pubmed: 37545785
doi: 10.1093/jscr/rjad439
pii: rjad439
pmc: PMC10401315
doi:
Types de publication
Case Reports
Langues
eng
Pagination
rjad439Informations de copyright
Published by Oxford University Press and JSCR Publishing Ltd. © The Author(s) 2023.
Déclaration de conflit d'intérêts
None declared.
Références
J Gynecol Oncol. 2020 May;31(3):e25
pubmed: 31912680
Gynecol Oncol. 2017 Apr;145(1):208-216
pubmed: 28209496
J Clin Oncol. 2018 Oct 5;:JCO1800454
pubmed: 30289732
BMJ Case Rep. 2013 Mar 20;2013:
pubmed: 23519508
J Clin Ultrasound. 2007 Oct;35(8):449-57
pubmed: 17636502
Diagn Interv Imaging. 2013 Dec;94(12):1291-8
pubmed: 24183708
Front Oncol. 2023 Mar 08;13:1149106
pubmed: 36969049
Oncotarget. 2019 Apr 2;10(26):2561-2575
pubmed: 31069017
Acta Oncol. 1990;29(2):185-91
pubmed: 2334571
Gynecol Oncol. 2003 Dec;91(3):636-42
pubmed: 14675691
Gynecol Oncol. 2003 Jun;89(3):460-9
pubmed: 12798712
Springerplus. 2014 Nov 18;3:678
pubmed: 25520907
Gynecol Oncol. 1996 Aug;62(2):226-9
pubmed: 8751554